Human ADSCs (Type 2 Diabetes Donor)

Human Adipose-Derived Stem Cells (ADSCs) from Type 2 Diabetes (T2D) donors are isolated from subcutaneous adipose tissue of donors with a clinically confirmed diagnosis of T2D. These multipotent mesenchymal stem cells are cryopreserved at passage 1 (P1) to maximize viability and preserve their native, disease-state characteristics.

This unique cell population provides an essential in vitro model for studying the interplay between stem cells and the autoimmune, metabolic, and vascular complications of T2D. Sourced from a disease-specific microenvironment, these ADSCs may exhibit altered paracrine signaling, differentiation potential, and immunomodulatory properties compared to those from healthy donors, offering critical insights for diabetes research and regenerative therapy development.

Cells are prepared and manufactured in an ISO 9001:2015 certified environment and ISO 5 cleanroom.